Related Experiment Video
Updated: Dec 18, 2025

Developing a Rat Model for Bipolar Disorder
Published on: May 2, 2025
Neurotropism of SARS-CoV-2: COVID-19 presenting with an acute manic episode
Jamie A Mawhinney1, Catherine Wilcock2, Hasan Haboubi3
1Academic Department of Vascular Surgery, King's College London, London, UK jamiemawhinney12@gmail.com.
Abstract:
A 41-year-old man with no significant medical history presented with acute behavioural disruption on the background of a 1-day history of severe headache and a 10-day history of dry cough and fever. He was sexually disinhibited with pressured speech and grandiose ideas. His behaviour worsened, necessitating heavy sedation and transfer to intensive care for mechanical ventilation despite no respiratory indication. Investigations confirmed that he was positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Neuroimaging and a lumbar puncture were normal. Initial screening for SARS-CoV-2 in the cerebrospinal fluid was negative although no validated assay was available. The patient's mental state remained abnormal following stepdown from intensive care. Psychiatric assessment found features consistent with acute mania, and he was detained under the Mental Health Act. This case indicates the need to consider COVID-19 in a wider series of clinical presentations and to develop a validated assay for SARS-CoV-2 in the cerebrospinal fluid.
Related Concept Videos
Bipolar Disorder
Mania and Antimanic Drugs: Overview
Psychosis and Antipsychotic Drugs: Overview
Drugs Affecting Neurotransmitter Release or Uptake
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Psychosis: Goals of Pharmacotherapy

